ICUI Insider Trading
ICU MEDICAL INC/DE | Surgical & Medical Instruments & Apparatus
Comprehensive Trading Performance Summary
The investment history of corporate insiders at ICU MEDICAL INC/DE provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-25 23:18 | 2025-11-25 | Woolson Daniel | Officer - VP, GM-Infusion Capital | SELL | $152.35 | 2,897 | $441,364 | 11,297 | -20.4% |
| 2025-11-12 18:55 | 2025-11-11 | Sanzone Virginia Ruth | Officer - VP, General Counsel | SELL | $142.35 | 930 | $132,381 | 5,456 | -14.6% |
| 2025-11-12 18:59 | 2025-11-11 | FINNEY ELISHA W | Director | OPT+S | $140.42 | 1,285 | $180,440 | 3,995 | 0.0% |
| 2025-08-28 00:51 | 2025-08-27 | Greenberg David C. | Director | BUY | $126.42 | 1,200 | $151,698 | 7,960 | +17.8% |
| 2025-08-15 02:07 | 2025-08-14 | Jain Vivek | Director, Officer - Chairman and CEO | BUY | $112.84 | 21,929 | $2,474,374 | 130,149 | +20.3% |
| 2025-05-30 21:34 | 2025-05-30 | Sanzone Virginia Ruth | Officer - VP, General Counsel | SELL | $133.62 | 700 | $93,537 | 6,386 | -9.9% |
| 2025-05-28 19:00 | 2025-05-27 | Voigtlander Christian B. | Officer - Chief Operating Officer | OPT+S | $129.75 | 9,930 | $1,288,372 | 6,088 | 0.0% |
| 2025-05-24 00:01 | 2025-05-22 | Voigtlander Christian B. | Officer - Chief Operating Officer | OPT+S | $130.02 | 9,918 | $1,289,503 | 4,903 | 0.0% |
| 2025-05-21 23:23 | 2025-05-20 | Voigtlander Christian B. | Officer - Chief Operating Officer | OPT+S | $135.05 | 9,788 | $1,321,840 | 3,711 | 0.0% |
| 2025-05-20 18:48 | 2025-05-19 | FINNEY ELISHA W | Director | SELL | $138.92 | 600 | $83,353 | 3,252 | -15.6% |
| 2025-05-20 00:28 | 2025-05-16 | Voigtlander Christian B. | Officer - Chief Operating Officer | OPT+S | $139.00 | 11,110 | $1,544,314 | 2,389 | 0.0% |
| 2025-05-15 23:55 | 2025-05-15 | Sousa Ben | Officer - Chief Information Officer | SELL | $137.36 | 2,000 | $274,714 | 479 | -80.7% |
| 2025-05-15 23:57 | 2025-05-14 | Voigtlander Christian B. | Officer - Chief Operating Officer | OPT+S | $137.10 | 11,111 | $1,523,301 | 2,389 | 0.0% |
| 2025-05-14 02:37 | 2025-05-13 | Greenberg David C. | Director | OPT+S | $143.66 | 1,942 | $278,992 | 6,760 | 0.0% |
| 2025-01-03 01:59 | 2025-01-02 | Jain Vivek | Director, Officer - Chairman and CEO | OPT+S | $155.48 | 1,373 | $213,474 | 104,593 | 0.0% |
| 2024-12-07 00:43 | 2024-12-06 | Woolson Daniel | Officer - VP, GM-Infusion Capital | SELL | $156.25 | 2,241 | $350,158 | 10,866 | -17.1% |
| 2024-12-03 05:12 | 2024-12-02 | Jain Vivek | Director, Officer - Chairman and CEO | OPT+S | $162.91 | 12,000 | $1,954,934 | 104,593 | 0.0% |
| 2024-11-28 01:26 | 2024-11-27 | Voigtlander Christian B. | Officer - Chief Operating Officer | OPT+S | $158.00 | 1,430 | $225,936 | 0 | 0.0% |
| 2024-11-28 01:36 | 2024-11-27 | Greenberg David C. | Director | OPT+S | $158.11 | 972 | $153,683 | 5,037 | 0.0% |
| 2024-11-27 02:20 | 2024-11-25 | Voigtlander Christian B. | Officer - Chief Operating Officer | OPT+S | $161.13 | 9,681 | $1,559,917 | 0 | 0.0% |
| 2024-11-05 03:32 | 2024-11-01 | Jain Vivek | Director, Officer - Chairman and CEO | OPT+S | $171.84 | 12,000 | $2,062,136 | 104,593 | 0.0% |
| 2024-10-02 00:16 | 2024-10-01 | Jain Vivek | Director, Officer - Chairman and CEO | OPT+S | $178.47 | 12,000 | $2,141,580 | 104,593 | 0.0% |
| 2024-09-04 01:05 | 2024-09-03 | Jain Vivek | Director, Officer - Chairman and CEO | OPT+S | $163.46 | 12,000 | $1,961,540 | 104,593 | 0.0% |
| 2024-08-31 00:26 | 2024-08-30 | Woolson Daniel | Officer - VP, GM-Infusion Capital | SELL | $163.22 | 2,502 | $408,370 | 13,107 | -16.0% |
| 2024-08-17 00:22 | 2024-08-16 | Jain Vivek | Director, Officer - Chairman and CEO | OPT+S | $156.04 | 12,000 | $1,872,480 | 104,593 | 0.0% |
| 2024-08-08 23:56 | 2024-08-08 | Sanzone Virginia Ruth | Officer - VP, General Counsel | SELL | $144.11 | 2,050 | $295,426 | 4,482 | -31.4% |
| 2024-05-31 01:03 | 2024-05-30 | Voigtlander Christian B. | Officer - Chief Operating Officer | SELL | $103.95 | 12,539 | $1,303,484 | 0 | -100.0% |
| 2024-05-17 02:30 | 2024-05-16 | FINNEY ELISHA W | Director | SELL | $104.95 | 300 | $31,484 | 2,129 | -12.4% |
| 2024-05-10 20:31 | 2024-05-10 | Sousa Ben | Officer - Chief Information Officer | SELL | $105.55 | 2,000 | $211,090 | 1,319 | -60.3% |
| 2024-03-16 00:24 | 2024-03-15 | Woolson Daniel | Officer - VP, GM-Infusion Capital | SELL | $98.27 | 791 | $77,733 | 13,980 | -5.4% |
| 2024-03-15 01:13 | 2024-03-14 | LOPEZ GEORGE A | Director | SELL | $101.87 | 7,978 | $812,741 | 877,343 | -0.9% |
| 2024-03-14 19:16 | 2024-03-12 | LOPEZ GEORGE A | Director | SELL | $101.51 | 1,522 | $154,497 | 885,321 | -0.2% |
| 2024-03-13 23:09 | 2024-03-11 | LOPEZ GEORGE A | Director | SELL | $103.01 | 3,412 | $351,465 | 316,231 | -1.1% |
| 2024-03-11 23:24 | 2024-03-08 | Sanzone Virginia Ruth | Officer - VP, General Counsel | OPT+S | $104.57 | 3,300 | $345,088 | 4,771 | 0.0% |
| 2024-03-11 23:22 | 2024-03-04 | LOPEZ GEORGE A | Director | SELL | $106.00 | 41,377 | $4,386,156 | 319,643 | -11.5% |
| 2024-03-05 21:42 | 2024-03-04 | Voigtlander Christian B. | Officer - Chief Operating Officer | SELL | $107.19 | 13,603 | $1,458,091 | 0 | -100.0% |
| 2024-03-02 00:16 | 2024-02-29 | Smiths Group International Holdings Ltd | Other | SELL | $106.08 | 830,000 | $88,042,250 | 1,670,000 | -33.2% |
| 2024-03-02 00:16 | 2024-02-29 | SMITHS GROUP PLC | Other | SELL | $106.08 | 830,000 | $88,042,250 | 1,670,000 | -33.2% |
| 2023-12-02 01:08 | 2023-12-01 | Woolson Daniel | Officer - VP, GM-Infusion Capital | SELL | $88.03 | 1,729 | $152,196 | 9,877 | -14.9% |
| 2023-09-11 19:27 | 2023-09-08 | Voigtlander Christian B. | Officer - Chief Operating Officer | SELL | $129.04 | 6,850 | $883,930 | 13,603 | -33.5% |
| 2023-07-15 00:36 | 2023-07-12 | Jain Vivek | Director, Officer - Chairman and CEO | OPT+S | $180.02 | 30,000 | $5,400,720 | 23,677 | 0.0% |
| 2023-06-15 17:22 | 2023-06-14 | Jain Vivek | Director, Officer - Chairman and CEO | OPT+S | $188.67 | 30,000 | $5,660,085 | 23,677 | 0.0% |
| 2023-06-07 23:26 | 2023-06-07 | FINNEY ELISHA W | Director | SELL | $190.41 | 194 | $36,940 | 1,481 | -11.6% |
| 2023-04-11 21:11 | 2023-04-11 | Sanzone Virginia Ruth | Officer - VP, General Counsel | SELL | $175.00 | 250 | $43,750 | 4,678 | -5.1% |
| 2023-04-06 00:07 | 2023-04-05 | Sanzone Virginia Ruth | Officer - VP, General Counsel | SELL | $170.00 | 458 | $77,860 | 4,928 | -8.5% |
| 2023-02-02 22:57 | 2023-02-02 | Woolson Daniel | Officer - VP, GM-Infusion Capital | SELL | $200.00 | 1,731 | $346,200 | 9,152 | -15.9% |
| 2022-11-16 01:24 | 2022-11-15 | Sanzone Virginia Ruth | Officer - VP, General Counsel | SELL | $160.12 | 325 | $52,039 | 3,046 | -9.6% |
| 2022-05-13 23:55 | 2022-05-12 | LOPEZ GEORGE A | Director | BUY | $172.91 | 25,835 | $4,467,256 | 281,444 | +10.1% |
| 2022-05-12 23:53 | 2022-05-12 | Sanzone Virginia Ruth | Officer - VP, General Counsel | SELL | $173.56 | 750 | $130,170 | 3,371 | -18.2% |
| 2022-05-12 22:30 | 2022-05-12 | FINNEY ELISHA W | Director | OPT+S | $170.53 | 217 | $37,005 | 1,933 | 0.0% |
How to Interpret $ICUI Trades
Not every insider transaction in ICU MEDICAL INC/DE is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ICUI shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for ICUI
Insider activity data for ICU MEDICAL INC/DE is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ICUI, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.